European Stocks Pause at Near Record Highs as Investors Await Catalysts, Weigh Geopolitical Risks
• European stocks paused as investors awaited fresh catalysts after last week's push to near record highs. The Stoxx Europe 600 was little changed.
• AstraZeneca shares climbed over 3% after trial data showed its drug Tagrisso slowed disease progression in lung cancer patients.
• US and global stocks have yet to respond to the Treasury selloff this month despite better economic data and hawkish policymaker comments.
• Investors are flagging that the Middle East war and shipping issues pose a major risk for earnings. Equities are expected to end the year higher but with volatility.
• Traders are looking ahead to European inflation data, earnings from Nvidia and mining giants, and any further policy support from China after mixed economic data.